Effectiveness of treatment for opioid use disorder: A national, five-year, prospective, observational study in England

被引:48
|
作者
Eastwood, Brian [1 ,2 ]
Strang, John [1 ]
Marsden, John [1 ,2 ]
机构
[1] Inst Psychiat Psychol & Neurosci, Addict Dept, Box 48,DeCrespigny Pk,Denmark Hill, London SE5 8AF, England
[2] Publ Hlth England, Alcohol Drugs & Tobacco Div, Hlth & Wellbeing Directorate, 2nd Floor,Skipton House,80 London Rd, London SE1 6LH, England
关键词
Treatment effectiveness; Opioid use disorder; National; Prospective; SUBSTANCE-ABUSE TREATMENT; OUTPATIENT TREATMENT COMPLETION; DRUG-USE; ADDICTION TREATMENT; HEROIN USERS; FOLLOW-UP; LONG-TERM; DEPENDENCE; IMPACT; RISK;
D O I
10.1016/j.drugalcdep.2017.03.013
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background. This the first 5-year effectiveness study of publicly funded treatment for opioid use disorder (OUD) in England. Methods: All adults initiating treatment in 2008/09 in all 149 local treatment systems reporting to the National Drug Treatment Monitoring System (n = 54,347). Admission polydrug use sub-populations were identified by Latent Class Analysis. The treatment outcome measure was 'successful completion and no re-presentation within six months' (SCNR) analysed by multilevel, multivariable logistic regression and funnel plots to contrast outcome by treatment system. Results: SCNR was achieved by 21.9%. Heroin and crack cocaine users were significantly less likely to achieve this outcome than patients who used heroin only (adjusted odds ratio [AOR] 0.90; 95% confidence interval [CI] 0.85-0.95). Older patients (AOR 1.09; CI 1.07-1.11), those employed (AOR 1.27; CI 1.18-1.37) and those enrolled for longer treatment were more likely to achieve the outcome measure. After risk adjustment, the local treatment systems that achieved substantially better outcome performance (14/149) had a lower rate of opiate prevalence in the local population at time of study initiation (incidence rate difference [IRD] 4.1; CI 4.0-4.2), fewer criminal offences per thousand (IRD 28.5; CI 28.1-28.8) and lower drug-related deaths per million (IRD 5.9; CI 5.9-5.9). Conclusions: In an English national study, one fifth of patients successful completed treatment for OUD and did not present for further treatment within six months. Longer time in treatment increases the probability of achieving and maintaining clinical benefit from treatment. After risk-adjustment, an important minority of treatment systems achieve substantially better outcome performance.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 50 条
  • [41] Borderline personality disorder among primary care depressive patients: A five-year study
    Riihimaki, Kirsi
    Vuorilehto, Maria
    Isometsa, Erkki
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 155 : 303 - 306
  • [42] Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: An observational study
    Bawor M.
    Dennis B.B.
    Tan C.
    Pare G.
    Varenbut M.
    Daiter J.
    Plater C.
    Worster A.
    Marsh D.C.
    Steiner M.
    Anglin R.
    Desai D.
    Thabane L.
    Samaan Z.
    Addiction Science & Clinical Practice, 10 (1)
  • [43] The Efficacy of Diabetic Foot Treatment in a "TOSF" Pattern: A Five-Year Retrospective Study
    Yan, Changbao
    Wang, Sheng
    Yang, Yaoguo
    Zhao, Liang
    Zhang, Jie
    Wang, Yanyang
    Liu, Dafang
    Geng, Yihe
    Chen, Zhong
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 1923 - 1939
  • [44] Five-Year Prospective Observational Study of African-American Men on Active Surveillance for Prostate Cancer Demonstrates Race Is Not Predictive of Oncologic Outcomes
    Pincus, Joshua
    Greenberg, Jacob W.
    Natale, Caleb
    Koller, Christopher R.
    Miller, Stephanie
    Silberstein, Jonathan L.
    Krane, L. Spencer
    ONCOLOGIST, 2023, 28 (02): : 149 - 156
  • [45] A five-year prospective study of bone mineral density in men and women with diabetes: The Fremantle Diabetes Study
    Hamilton, Emma J.
    Rakic, Valentina
    Davis, Wendy A.
    Chubb, S. A. Paul
    Kamber, Niklaus
    Prince, Richard L.
    Davis, Timothy M. E.
    ACTA DIABETOLOGICA, 2012, 49 (02) : 153 - 158
  • [46] National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018
    Schuler, Megan S.
    Saloner, Brendan
    Gordon, Adam J.
    Dick, Andrew W.
    Stein, Bradley D.
    SUBSTANCE ABUSE, 2023, 44 (03) : 154 - 163
  • [47] A Pilot Study of Automated Pupillometry in the Treatment of Opioid Use Disorder
    Peeler, Crandall E.
    Gorgy, Merit
    Sadlak, Natalie
    Sathe, Shaleen
    Tamashunas, Nina
    Fiorello, Marissa G.
    Cabral, Howard
    Paasche-Orlow, Michael K.
    Weinstein, Zoe M.
    JOURNAL OF ADDICTION MEDICINE, 2021, 15 (06) : 477 - 483
  • [48] Reactivation of hepatitis B virus replication due to cytotoxic therapy: a five-year prospective study
    Francisci, Daniela
    Falcinelli, Flavio
    Schiaroli, Elisabetta
    Capponi, Monia
    Belfiori, Barbara
    Cecchini, Enisia
    Baldelli, Franco
    TUMORI JOURNAL, 2012, 98 (02): : 220 - 224
  • [49] Take it or leave: a five-year prospective study of workplace bullying and indicators of expulsion in working life
    Glambek, Mats
    Skogstad, Anders
    Einarsen, Stale
    INDUSTRIAL HEALTH, 2015, 53 (02) : 160 - 170
  • [50] Prospective, five-year follow-up study of patients with symptomatic uncomplicated diverticular disease
    Salem, Tarek A.
    Molloy, Richard G.
    O'Dwyer, Patrick J.
    DISEASES OF THE COLON & RECTUM, 2007, 50 (09) : 1460 - 1464